News Articles on 'Respiratory Medicine'

Back to All Specialties


Medtronic announces preliminary PRODIGY results, identifying patients at high risk for opioid-induced respiratory compromise

The PRODIGY score performed well, identifying 76 percent of patients with confirmed respiratory depression (AUC=0.7620). Publication of full results is expected in 2019. The study, presented at the Society of Critical Care Medicine's (SCCM) 48th Critical ...

Source: DOTmed
Published: 18 Feb 2019

China's top medical research institution sets up respiratory medicine institute

BEIJING, Jan. 20 (Xinhua) -- A respiratory medicine institute was set up under the Chinese Academy of Medical Sciences, China's top medical research institution, in Beijing Sunday. The new institute is expected to improve the prevention and treatment of ...

Source: Xinhua
Published: 20 Jan 2019

Aridis Pharmaceuticals Announces Publication of Positive AR-301 Phase 1/2a Data in "Intensive Care Medicine" and "The Lancet Respiratory Medicine"

- Positive safety and efficacy trends of AR-301 in Phase 1/2a clinical trial was presented at the 31st Annual Congress of the European Society of Intensive Care Medicine - Potential breakthrough approach to the treatment of critically ill patients with ...

Source: Yahoo Finance
Published: 07 Nov 2018

The Lancet Respiratory Medicine publishes first Phase III trial for PT010 triple combination therapy in moderate to very severe COPD

and published in The Lancet Respiratory Medicine.1 Dr Colin Reisner, Head of Respiratory, Global Medicines, said: “We are encouraged by the results of the KRONOS trial which demonstrate PT010’s efficacy in improving lung function and its potential ...

Source: cision.com
Published: 16 Sep 2018

New blood test found to predict onset of TB up to two years in advance

About the American Journal of Respiratory and Critical Care Medicine (AJRCCM): The AJRCCM is a peer-reviewed journal published by the American Thoracic Society. The Journal takes pride in publishing the most innovative science and the highest quality ...

Source: EurekAlert!
Published: 06 Apr 2018

GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS

Mechelen, Belgium; 20 May 2018; 20.30 CET; Galapagos NV (Euronext & NASDAQ: GLPG) announces publication milestones on GLPG1690 in idiopathic pulmonary fibrosis (IPF). In addition to presenting three abstracts on investigational drug GLPG1690 at the ...

Source: GlobeNewswire
Published: 20 May 2018

The Results of the OCS™ Lung INSPIRE Trial Published in The Lancet Respiratory Medicine Journal.

ANDOVER, Massachusetts, April 12, 2018 /PRNewswire/ -- TransMedics, Inc., a medical technology company that is transforming the important therapy of solid organ transplantation for patients with end-stage lung, heart and liver failure, announced today ...

Source: Markets Insider
Published: 12 Apr 2018

Infant Dies in Gaza from Lack of Respiratory Medicine due to Israeli Siege

The Palestinian Health Ministry in Gaza reported Tuesday that a five-day old baby died in the intensive care unit of the Al-Hilal Emirati Hospital in Gaza. The infant, Hadia Mohammad Abu Hilal, died because of the lack of special medication required for ...

Source: International Middle East Media Center
Published: 17 Jan 2018

AstraZeneca boosts early respiratory medicine with Pieris deal

LONDON (Reuters) - AstraZeneca boosted its early-stage respiratory medicine pipeline on Wednesday by signing a deal with Pieris Pharmaceuticals to develop novel inhaled drugs that could fight asthma in new ways. Pieris will get upfront and near-term ...

Source: Reuters
Published: 03 May 2017

The molecular epidemiology of respiratory viruses associated with asthma attacks: A single-center observational study in Japan

a Kyorin University School of Medicine, Department of Respiratory Medicine, Mitaka City b Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan. Correspondence: Takeshi Saraya, Department of Respiratory Medicine ...

Source: LWW Journals
Published: 27 May 2017

Network science meets respiratory medicine for OSAS phenotyping and severity prediction

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed.

Source: PeerJ
Published: 09 May 2017

Lancet Respiratory Medicine

The Lancet Respiratory Medicine considers any original research contribution that advocates change in or illuminates clinical practice and informative reviews on any topic connected with respiratory medicine and critical care.

Source: Phys.org
Published: 22 Jun 2017

Clinical Programs

Yale Pediatric Respiratory Medicine faculty see patients at several locations for a variety of respiratory problems including asthma, cystic fibrosis, chronic lung disease in both infants and older children, sleep related disordered breathing, and ...

Source: medicine.yale.edu
Published: 24 Jan 2018

Expert in respiratory medicine from Helmshore awarded prestigious medal

AN expert in respiratory medicine has been awarded a prestigious medal. Professor Peter Ormerod, from Helmshore, won the British Thoracic Society medal at the society’s winter scientific meeting. He said he was ‘delighted’ to receive the accolade at ...

Source: Lancashire Telegraph
Published: 13 Dec 2017

Merck: Respiratory Medicine Running Out Of Breath

Merck's (NYSE:MRK) leading respiratory therapeutic Singulair (Montelukast), a once-a-day oral medicine for the chronic treatment of asthma and for the relief of symptoms of allergic rhinitis which generated more than $44 billion of revenue since its launch ...

Source: Seeking Alpha
Published: 26 Jun 2013

The Case Against Cough Medicine

a respiratory specialist at the University of Hull and founding member of the International Society for the Study of Cough, recently cited a randomized controlled trial involving 163 patients that showed a chocolate-based cough medicine to be superior to ...

Source: nytimes.com
Published: 18 Feb 2019

GSK share price hit by clinical trial failure of major new respiratory medicine Breo

Today, GSK released disappointing clinical results for a new respiratory drug it hoped would bring in billions of pounds worth of sales. Breo, a treatment for asthma and chronic obstructive pulmonary disease (COPD), managed to extend life expectancy by ...

Source: City A.M.
Published: 09 Sep 2015

Crofton and Douglas's Respiratory Diseases

In the 8 years since the publication of the previous edition of this book, significant advances have been made in virtually all areas of respiratory medicine. For three authors to have written such a comprehensive text on so many topics and to have done it ...

Source: Annals.org
Published: 01 Nov 2017

Teva Pharma (TEVA) Phase III Reslizumab Data Published in The Lancet Respiratory Medicine

Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) announced today that The Lancet Respiratory Medicine has published data from two replicate 52-week Phase III global studies on the company’s investigational anti-interleukin-5 (IL-5) monoclonal antibody ...

Source: StreetInsider
Published: 23 Feb 2015

Medtronic Announces Preliminary PRODIGY Results: a Global Study to Identify Patients at High Risk for Opioid-Induced Respiratory Compromise

The PRODIGY score performed well, identifying 76 percent of patients with confirmed respiratory depression (AUC=0.7620). Publication of full results is expected in 2019. The study, presented at the Society of Critical Care Medicine's (SCCM) 48th Critical ...

Source: MarketWatch
Published: 17 Feb 2019

AstraZeneca boosts early respiratory medicine with Pieris deal

LONDON (Reuters) - AstraZeneca boosted its early-stage respiratory medicine pipeline on Wednesday by signing a deal with Pieris Pharmaceuticals to develop novel inhaled drugs that could fight asthma in new ways. Pieris will get upfront and near-term ...

Source: Yahoo Singapore Finance
Published: 03 May 2017